FDA Recommends Alternative Testing Methods for Quidel’s Triage Cardiac Panel
The FDA cautions health providers to stop using the Quidel Triage Cardiac Panel due to potential inaccuracies in troponin levels. Alternatives are recommended to ensure accurate diagnoses for myocardial infarction.